These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2357958)

  • 41. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vigabatrin: rational treatment for chronic epilepsy.
    Ring HA; Heller AJ; Farr IN; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1051-5. PubMed ID: 2292696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures.
    Borlot F; Wither RG; Ali A; Wu N; Verocai F; Andrade DM
    Epilepsy Res; 2014 Nov; 108(9):1642-51. PubMed ID: 25223728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Losigamone add-on therapy for partial epilepsy.
    Xiao Y; Luo M; Wang J; Luo H
    Cochrane Database Syst Rev; 2015 Dec; (12):CD009324. PubMed ID: 26661741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lamotrigine as an add-on therapy in intractable paediatric epilepsy--the Kuala Lumpur Hospital experience.
    Vigneswari G; Sofiah A; Hussain IH
    Med J Malaysia; 2001 Sep; 56(3):359-64. PubMed ID: 11732083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy.
    Bauer J; Buchmüller L; Reuber M; Burr W
    Acta Neurol Scand; 2008 Jan; 117(1):55-9. PubMed ID: 17961196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
    Usui N; Akamatsu N; Nakasato N; Ohnishi A; Kaneko S; Hiramatsu H; Saeki K; Miyagishi H; Inoue Y
    Seizure; 2018 Nov; 62():26-32. PubMed ID: 30267941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clobazam in the treatment of epilepsy: a review of the literature.
    Remy C
    Epilepsia; 1994; 35 Suppl 5():S88-91. PubMed ID: 8039479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology and treatment of chronic and refractory epilepsy.
    Shorvon SD
    Epilepsia; 1996; 37 Suppl 2():S1-S3. PubMed ID: 8641240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England.
    Valentin A; Moran N; Hadden R; Oakes A; Elwes R; Delamont R; Mullatti N; Nashef L
    Seizure; 2009 Jul; 18(6):450-2. PubMed ID: 19213577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
    Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ
    Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topiramate in patients with learning disability and refractory epilepsy.
    Kelly K; Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of epilepsy: an overview of clinical practices.
    Wilder BJ
    Neurology; 1995 Mar; 45(3 Suppl 2):S7-11. PubMed ID: 7898746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K; Sander JW
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy.
    Selwa LM; Schmidt SL; Malow BA; Beydoun A
    Epilepsia; 2003 Dec; 44(12):1568-72. PubMed ID: 14636329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monotherapy versus polytherapy in epilepsy: a framework for patient management.
    Schneiderman JH
    Can J Neurol Sci; 1998 Nov; 25(4):S9-13. PubMed ID: 9827239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: a multicentre study in epilepsy clinics in the United Kingdom (UK).
    Flores L; Kemp S; Colbeck K; Moran N; Quirk J; Ramkolea P; von Oertzen TJ; Nashef L; Richardson MP; Goulding P; Elwes R
    Seizure; 2012 Sep; 21(7):512-7. PubMed ID: 22698379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.